Skip to content
Delayed ~15 min

DSGN DESIGN THERAPEUTICS

Health Care · Russell 2000

Next earnings: not announced yet

What 10 analyst firms say about DESIGN THERAPEUTICS: their latest ratings, price targets and how far the stock is from them. How it works

10.21 USD+0.54 (+5.58%) today
Price as of 6 Nov 16:00 ET

Analyst window: Latest analyst report within last 1 year

Analyst view · last 1Y

+105.7%to the avg target 21.00 USD+10.79 USD
Buy 8 · Hold 1 · Sell 0

9 rated views · 10 analyst/firm records · 10 firms

Latest report13 Oct 2026avg report date 23 Jun
Target rangePrice is below every target

Radar score

  • Russell 2000 · Top Picks · 6MBelow the Radar threshold of 8077
  • Russell 2000 · Safest consensus · 6MBelow the Radar threshold of 8054

Recent analyst activity · last 90 days

Our tracked history has 4 reports on DSGN from 4 analyst firms in the last 90 days (10 firms in the past year).

Comparing each firm's latest target with its previous one: 2 raised their price target and 1 has its first observed target in the past year.

No firm's latest available rating differs from its previous one.

Latest observed target change: RBC Capital raised its target from $13.00 (set 20 Nov 2025) to $19.00 on 5 Nov 2026.

Last 1 year. Latest opinion per identifiable analyst within the last 1 year. BUY / HOLD / SELL each count one current analyst vote; unnamed firm records are a fallback.

FirmAnalystLatest ratingReport dateLatest target (USD)
Cantor FitzgeraldYanni SouroutzidisBuy12 May 2026—
Craig-HallumAdam VogelBuy18 May 202622.00 USD
JefferiesFaisal KhurshidBuy16 Mar 202615.00 USD
Leerink PartnersJoseph P SchwartzBuy13 Oct 202622.00 USD
OppenheimerKostas BiliourisBuy4 May 202621.00 USD
Piper SandlerYasmeen RahimiBuy27 May 202620.00 USD
RBC Capital MarketsLeonid TimashevBuy10 Mar 2026Conflicting reports · excluded
Weiss RatingsUnnamed analyst—15 Oct 2026—
Wells FargoTianqi HangBuy2 Oct 202626.00 USD
Data feed RESEARCHResearch TeamHold15 Jun 2026—

Partial coverage · checked 6 Nov (6 Nov 2026, 07:00 ET). Some research records could not be refreshed. Cached records retained. Prices stream live during the US session; otherwise stored prices delayed about 15 minutes. A summary of analyst opinion, not investment advice.